AI-assisted, human-published
11/02/2026 /Funding Events
Dren Bio Raises $350M in Oversubscribed Round Led by Juvia Group and Lightspeed
Private financing of $350 million reinforces investor confidence in Dren Bio’s first-in-class antibody therapies and accelerates its oncology and autoimmune programs.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com